Literature DB >> 11959577

High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.

Igor Mokrousov1, Olga Narvskaya, Tatiana Otten, Elena Limeschenko, Lidia Steklova, Boris Vyshnevskiy.   

Abstract

A total of 204 isoniazid (INH)-resistant strains of Mycobacterium tuberculosis isolated from different patients in the northwestern region of Russia from 1996 to 2001 were screened by a PCR-restriction fragment length polymorphism (RFLP) assay. This assay uses HapII cleavage of an amplified fragment of the katG gene to detect the transversion 315AGC-->ACC (Ser-->Thr), which is associated with INH resistance. This analysis revealed a 93.6% prevalence of the katG S315T mutation in strains from patients with both newly and previously diagnosed cases of tuberculosis (TB). This mutation was not found in any of 57 INH-susceptible isolates included in the study. The specificity of the assay was 100%; all isolates that contained the S315T mutation were classified as resistant by a culture-based susceptibility testing method. The Beijing genotype, defined by IS6110-RFLP analysis and the spacer oligonucleotide typing (spoligotyping) method, was found in 60.3% of the INH-resistant strains studied. The katG S315T shift was more prevalent among Beijing genotype strains than among non-Beijing genotype strains: 97.8 versus 84.6%, respectively, for all isolates, including those from patients with new and previously diagnosed cases, isolated from 1999 to 2001 and 100.0 versus 86.5%, respectively, for isolates from patients with new cases isolated from 1996 to 2001. The design of this PCR-RFLP assay allows the rapid and unambiguous identification of the katG 315ACC mutant allele. The simplicity of the assay permits its implementation into routine practice in clinical microbiology laboratories in regions with a high incidence of TB where this mutation is predominant, including northwestern Russia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959577      PMCID: PMC127151          DOI: 10.1128/AAC.46.5.1417-1424.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy.

Authors:  T C Victor; A M Jordaan; A van Rie; G D van der Spuy; M Richardson; P D van Helden; R Warren
Journal:  Tuber Lung Dis       Date:  1999

2.  Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru.

Authors:  P Escalante; S Ramaswamy; H Sanabria; H Soini; X Pan; O Valiente-Castillo; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

3.  Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore.

Authors:  A S Lee; I H Lim; L L Tang; A Telenti; S Y Wong
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 4.  The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.

Authors:  R A Slayden; C E Barry
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

Review 5.  Tuberculosis in Russia.

Authors:  M I Perelman
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

6.  Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.

Authors:  P Kiepiela; K S Bishop; A N Smith; L Roux; D F York
Journal:  Tuber Lung Dis       Date:  2000

7.  Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis.

Authors:  M L Beggs; K D Eisenach; M D Cave
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

8.  Molecular fingerprinting of Mycobacterium tuberculosis strains isolated in Vietnam using IS6110 as probe.

Authors:  T K Le; K H Bach; M L Ho; N V Le; T N Nguyen; D Chevrier; J L Guesdon
Journal:  Tuber Lung Dis       Date:  2000

9.  Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.

Authors:  A S Piatek; A Telenti; M R Murray; H El-Hajj; W R Jacobs; F R Kramer; D Alland
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

10.  Genetic variation and evolutionary origin of the direct repeat locus of Mycobacterium tuberculosis complex bacteria.

Authors:  J D van Embden; T van Gorkom; K Kremer; R Jansen; B A van Der Zeijst; L M Schouls
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

View more
  68 in total

1.  Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania.

Authors:  Daiva Bakonyte; Aurelija Baranauskaite; Jurate Cicenaite; Anaida Sosnovskaja; Petras Stakenas
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

2.  PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia.

Authors:  I Mokrousov; T Otten; A Vyazovaya; E Limeschenko; M L Filipenko; C Sola; N Rastogi; L Steklova; B Vyshnevskiy; O Narvskaya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-03       Impact factor: 3.267

3.  Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis.

Authors:  Márcia Susana N Silva; Simone G Senna; Marta O Ribeiro; Andréia R M Valim; Maria Alice Telles; Afrânio Kritski; Glenn P Morlock; Robert C Cooksey; Arnaldo Zaha; Maria Lucia R Rossetti
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

4.  Analysis of the allelic diversity of the mycobacterial interspersed repetitive units in Mycobacterium tuberculosis strains of the Beijing family: practical implications and evolutionary considerations.

Authors:  Igor Mokrousov; Olga Narvskaya; Elena Limeschenko; Anna Vyazovaya; Tatiana Otten; Boris Vyshnevskiy
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.

Authors:  V Nikolayevsky; T Brown; Y Balabanova; M Ruddy; I Fedorin; F Drobniewski
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

6.  Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

Authors:  Corinne Surcouf; Seiha Heng; Catherine Pierre-Audigier; Véronique Cadet-Daniel; Amine Namouchi; Alan Murray; Brigitte Gicquel; Bertrand Guillard
Journal:  BMC Infect Dis       Date:  2011-09-28       Impact factor: 3.090

7.  Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.

Authors:  Doris Hillemann; Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain.

Authors:  S Samper; M J Iglesias; M J Rabanaque; L I Gómez; M C Lafoz; M S Jiménez; A Ortega; M A Lezcano; D Van Soolingen; C Martín
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.

Authors:  Min Zhang; Jun Yue; Yan-Ping Yang; Hong-Mei Zhang; Jian-Qiang Lei; Rui-Liang Jin; Xue-Lian Zhang; Hong-Hai Wang
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

10.  Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.

Authors:  Paolo Miotto; Federica Piana; Valeria Penati; Filippo Canducci; Giovanni Battista Migliori; Daniela Maria Cirillo
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.